{"protocolSection":{"identificationModule":{"nctId":"NCT00849680","orgStudyIdInfo":{"id":"V520-016"},"secondaryIdInfos":[{"id":"2009_548"}],"organization":{"fullName":"Merck Sharp & Dohme LLC","class":"INDUSTRY"},"briefTitle":"A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)","officialTitle":"A Phase I Dose-Ranging Study of the Safety, Tolerability, and Immunogenicity of the Merck Trivalent Adenovirus Serotype 5 HIV-1 Gag/Pol/Nef Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in a Prime-Boost Regimen in Healthy Adults"},"statusModule":{"statusVerifiedDate":"2015-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2003-04"},"primaryCompletionDateStruct":{"date":"2005-03","type":"ACTUAL"},"completionDateStruct":{"date":"2010-02","type":"ACTUAL"},"studyFirstSubmitDate":"2009-02-20","studyFirstSubmitQcDate":"2009-02-20","studyFirstPostDateStruct":{"date":"2009-02-24","type":"ESTIMATED"},"resultsFirstSubmitDate":"2011-06-09","resultsFirstSubmitQcDate":"2011-06-09","resultsFirstPostDateStruct":{"date":"2011-07-07","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-01-21","lastUpdatePostDateStruct":{"date":"2015-02-02","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Merck Sharp & Dohme LLC","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The goal of this study is to understand the safety, tolerability and immunogenicity of the Merck Trivalent Adenovirus Serotype 5 HIV-1 gag/pol/nef\n\nVaccine (MRKAd 5 HIV-1 gag/pol/nef) vaccine in healthy human volunteers compared to placebo. The study will also evaluate a number of dose levels and the necessity for and timing of booster injections.","detailedDescription":"The study will proceed in four stages. Following stages I, II and III, all subjects will have the Postdose 1 (PD1) clinical and laboratory safety data reviewed by the Safety Evaluation Committee (SEC). If these data are acceptable, the next stage will be initiated.\n\n* In Stage I, participants will be randomized to receive 3 doses of the 3x10\\^9vp/dose level Trivalent vaccine or placebo.\n* In Stage II, participants will be randomized to receive 2 or 3 doses of the 3x10\\^10vp/dose level Trivalent vaccine or placebo.\n* In Stage III, participants will be randomized to receive 3 doses of the Trivalent vaccine with titers of 1x10\\^11vp/dose, 3x10\\^6vp/dose, 3x10\\^7vp/dose, or 3x10\\^8vp/dose or placebo.\n* In Stage IV, participants will be randomized to all treatment groups. In addition, some participants will be randomized to an MRKAd 5 HIV-1 gag Monovalent vaccine. In this stage, participants will be pre-stratified by baseline Ad5 titers (=\\<200, and \\>200), to ensure an even distribution of participants with high and low Ad5 titers across the various treatment groups."},"conditionsModule":{"conditions":["HIV-1","HIV Infections"],"keywords":["HIV Seronegativity","Preventive Vaccine"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE1"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":317,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Participants receiving 1.0 ml of placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine or the placebo to the MRKAd5 HIV-1 gag vaccine injected intramuscularly in a 3-dose regimen at Day 1, Week 4 and Week 26 or a 2-dose regimen at Day 1 and Week 26 or Day 1 and Week 4.","interventionNames":["Other: Comparator: Placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine","Biological: Comparator: Placebo to MRKAd5 HIV-1 gag vaccine"]},{"label":"Monovalent MRKAd5 HIV-1 gag vaccine (1x10^9 vp/dose)","type":"EXPERIMENTAL","description":"Participants receiving 1.0 ml of the Monovalent MRKAd5 HIV-1 gag vaccine (1x10\\^9 vp/dose) injected intramuscularly in a 3-dose regimen at Day 1, Week 4 and Week 26.","interventionNames":["Biological: Monovalent MRKAd5 HIV-1 gag vaccine (1x10^9 vp/dose)"]},{"label":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^6 vp/dose)","type":"EXPERIMENTAL","description":"Participants receiving 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^6 vp/dose) injected intramuscularly in a 3-dose regimen at Day 1, Week 4 and Week 26.","interventionNames":["Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^6 vp/dose)"]},{"label":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^7 vp/dose)","type":"EXPERIMENTAL","description":"Participants receiving 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^7 vp/dose) injected intramuscularly in a 3-dose regimen at Day 1, Week 4 and Week 26.","interventionNames":["Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^7 vp/dose)"]},{"label":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^8 vp/dose)","type":"EXPERIMENTAL","description":"Participants receiving 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^8 vp/dose) injected intramuscularly in a 3-dose regimen at Day 1, Week 4 and Week 26.","interventionNames":["Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^8 vp/dose)"]},{"label":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^9 vp/dose)","type":"EXPERIMENTAL","description":"Participants receiving 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^9 vp/dose) injected intramuscularly in a 3-dose regimen at Day 1, Week 4 and Week 26.","interventionNames":["Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^9 vp/dose)"]},{"label":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^10 vp/dose)","type":"EXPERIMENTAL","description":"Participants receiving 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^10 vp/dose) injected intramuscularly in a 3-dose regimen at Day 1, Week 4 and Week 26, or in a 2-dose regimen at Day 1 and Week 4 (with no vaccine administered at Week 26) or Day 1 and Week 26 (with placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine administered at Week 4)","interventionNames":["Other: Comparator: Placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine","Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^10 vp/dose)"]},{"label":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10^11 vp/dose)","type":"EXPERIMENTAL","description":"Participants receiving 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10\\^11 vp/dose) injected intramuscularly in a 3-dose regimen at Day 1, Week 4 and Week 26.","interventionNames":["Biological: Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10^11 vp/dose)"]}],"interventions":[{"type":"OTHER","name":"Comparator: Placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine","description":"Placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine.","armGroupLabels":["Placebo","Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^10 vp/dose)"]},{"type":"BIOLOGICAL","name":"Monovalent MRKAd5 HIV-1 gag vaccine (1x10^9 vp/dose)","description":"Monovalent MRKAd5 HIV-1 gag vaccine (1x10\\^9 vp/dose)","armGroupLabels":["Monovalent MRKAd5 HIV-1 gag vaccine (1x10^9 vp/dose)"],"otherNames":["V520"]},{"type":"BIOLOGICAL","name":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^6 vp/dose)","description":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^6 vp/dose)","armGroupLabels":["Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^6 vp/dose)"],"otherNames":["V520"]},{"type":"BIOLOGICAL","name":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^7 vp/dose)","description":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^7 vp/dose)","armGroupLabels":["Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^7 vp/dose)"],"otherNames":["V520"]},{"type":"BIOLOGICAL","name":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^8 vp/dose)","description":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^8 vp/dose)","armGroupLabels":["Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^8 vp/dose)"],"otherNames":["V520"]},{"type":"BIOLOGICAL","name":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^9 vp/dose)","description":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^9 vp/dose)","armGroupLabels":["Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^9 vp/dose)"],"otherNames":["V520"]},{"type":"BIOLOGICAL","name":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^10 vp/dose)","description":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^10 vp/dose)","armGroupLabels":["Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10^10 vp/dose)"],"otherNames":["V520"]},{"type":"BIOLOGICAL","name":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10^11 vp/dose)","description":"Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10\\^11 vp/dose)","armGroupLabels":["Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10^11 vp/dose)"],"otherNames":["V520"]},{"type":"BIOLOGICAL","name":"Comparator: Placebo to MRKAd5 HIV-1 gag vaccine","description":"Placebo to the MRKAd5 HIV-1 gag vaccine.","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants With Adverse Experiences","description":"Adverse experiences (AE) collected include serious and non serious systemic AEs, and injection-site AEs.\n\nSystemic and Laboratory AEs include any unfavorable \\& unintended change in the structure, function, or chemistry of the body.\n\nInjection-site AEs include any swelling, redness, pain or tenderness at the injection site. All injection site AEs were collected up to 5 days after any vaccine dose.","timeFrame":"up to 260 weeks after first vaccination"},{"measure":"Number of Participants With Laboratory Adverse Experiences","description":"Laboratory AEs were based on a grading system considering the severity of abnormal laboratory values in participants and reflect any unfavorable and unintentional change in function, or chemistry of the body.\n\nAll laboratory AEs were collected up to 29 days after any vaccine dose.","timeFrame":"up to 260 weeks after first vaccination"},{"measure":"Immune Response by Levels of Unfractionated Gag, Pol, and Nef-specific IFN-gamma Following a 3-dose Vaccine Regimen","description":"Participants expressing HIV antigens (gag, pol and nef) secrete antigen specific interferon-gamma (IFN-gamma). Levels of unfractionated gag, pol, and nef-specific IFN-gamma were to be measured using an Enzyme Linked Immunospot Assay (ELISPOT), which measures spot forming cells per 10\\^6 peripheral blood mononuclear cells (SFC per million PBMCs).","timeFrame":"4 weeks after booster injection"},{"measure":"Immune Response by Levels of Unfractionated Gag, Pol, and Nef-specific IFN-gamma Following a 2-dose Vaccine Regimen","description":"Participants expressing HIV antigens (gag, pol and nef) secrete antigen specific interferon-gamma (IFN-gamma). Levels of unfractionated gag, pol, and nef-specific IFN-gamma were to be measured using an Enzyme Linked Immunospot Assay (ELISPOT), which measures spot forming cells per 10\\^6 peripheral blood mononuclear cells (SFC per million PBMCs).\n\nNo immunogenicity analyses were performed because the results from a previous study, V520-023 (NCT00095576), which used the same vaccine as the one used in this study (NCT00849680) proved it was not efficacious.","timeFrame":"4 weeks after booster injection"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects 18 Years to 45 Years in Stages I-III and 18 Years to 50 Years in Stage IV.\n* Subject is in good general health\n* Subjects of reproductive potential agree to use acceptable method of birth control through study\n* Subject tests negative for Hepatitis B, Hepatitis C, and HIV\n\nExclusion Criteria:\n\n* Subject has a recent history of fever at time of vaccination\n* Subject has received immune globulin or blood product 3 months prior to injection\n* Subject has been vaccinated with live virus vaccine 30 days prior to receipt of first dose\n* Subject has been vaccinated with inactivated vaccine with 14 days prior to receipt of first dose\n* Subject has a chronic medical condition that is considered progressive\n* Subject has history of malignancy\n* Subject weighs less than 105 lb.\n* Female subject is pregnant or breast feeding, Male subject is planning to impregnate during the first year of study\n* Subject has contraindication to intramuscular injection\n* Subject has a tattoo on the deltoid region of the arm or the injection of Depo-Provera\n* Subject is unlikely or unwilling to adhere to lower risk sex practices during the course of the study","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Medical Monitor","affiliation":"Merck Sharp & Dohme LLC","role":"STUDY_DIRECTOR"}]},"referencesModule":{"references":[{"pmid":"18433307","type":"BACKGROUND","citation":"Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM, Brown SJ, Kulkarni P, Dubey SA, Kierstead LS, Casimiro DR, Mogg R, DiNubile MJ, Shiver JW, Leavitt RY, Robertson MN, Mehrotra DV, Quirk E; Merck V520-016 Study Group. Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults. Clin Infect Dis. 2008 Jun 1;46(11):1769-81. doi: 10.1086/587993."},{"pmid":"21695251","type":"DERIVED","citation":"Li F, Finnefrock AC, Dubey SA, Korber BT, Szinger J, Cole S, McElrath MJ, Shiver JW, Casimiro DR, Corey L, Self SG. Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study. PLoS One. 2011;6(6):e20479. doi: 10.1371/journal.pone.0020479. Epub 2011 Jun 10."},{"pmid":"21203546","type":"DERIVED","citation":"Hutnick NA, Carnathan DG, Dubey SA, Cox KS, Kierstead L, Makadonas G, Ratcliffe SJ, Lasaro MO, Robertson MN, Casimiro DR, Ertl HC, Betts MR. Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality. PLoS One. 2010 Dec 22;5(12):e14385. doi: 10.1371/journal.pone.0014385."}]}},"resultsSection":{"participantFlowModule":{"recruitmentDetails":"317 participants were randomized. 2 did not receive any study medication. Therefore, the safety population was 315.","groups":[{"id":"FG000","title":"Placebo","description":"2 or 3 doses of 1.0 mg of placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine or 3 doses of placebo to the MRKAd5 HIV-1 gag vaccine injected intramuscularly."},{"id":"FG001","title":"Monovalent MRKAd5 HIV-1 Gag Vaccine (1x10^9 vp/Dose)","description":"3 doses of 1.0 ml of the Monovalent MRKAd5 HIV-1 gag vaccine (1x10\\^9 vp/dose) injected intramuscularly."},{"id":"FG002","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^6 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^6 vp/dose) injected intramuscularly."},{"id":"FG003","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^7 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^7 vp/dose) injected intramuscularly."},{"id":"FG004","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^8 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^8 vp/dose) injected intramuscularly."},{"id":"FG005","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^9 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^9 vp/dose) injected intramuscularly."},{"id":"FG006","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^10 vp/Dose)","description":"2 or 3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^10 vp/dose) injected intramuscularly."},{"id":"FG007","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (1x10^11 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10\\^11 vp/dose) injected intramuscularly."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"27"},{"groupId":"FG001","numSubjects":"13"},{"groupId":"FG002","numSubjects":"42"},{"groupId":"FG003","numSubjects":"42"},{"groupId":"FG004","numSubjects":"42"},{"groupId":"FG005","numSubjects":"42"},{"groupId":"FG006","numSubjects":"78"},{"groupId":"FG007","numSubjects":"31"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"16"},{"groupId":"FG001","numSubjects":"10"},{"groupId":"FG002","numSubjects":"27"},{"groupId":"FG003","numSubjects":"28"},{"groupId":"FG004","numSubjects":"32"},{"groupId":"FG005","numSubjects":"27"},{"groupId":"FG006","numSubjects":"61"},{"groupId":"FG007","numSubjects":"23"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"11"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"15"},{"groupId":"FG003","numSubjects":"14"},{"groupId":"FG004","numSubjects":"10"},{"groupId":"FG005","numSubjects":"15"},{"groupId":"FG006","numSubjects":"17"},{"groupId":"FG007","numSubjects":"8"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"2"},{"groupId":"FG007","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"7"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"12"},{"groupId":"FG003","numSubjects":"11"},{"groupId":"FG004","numSubjects":"8"},{"groupId":"FG005","numSubjects":"11"},{"groupId":"FG006","numSubjects":"12"},{"groupId":"FG007","numSubjects":"5"}]},{"type":"Subject moved","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"2"},{"groupId":"FG007","numSubjects":"2"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"2"},{"groupId":"FG004","numSubjects":"2"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"1"}]},{"type":"Subject unable to comply with protocol","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Placebo","description":"2 or 3 doses of 1.0 mg of placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine or 3 doses of placebo to the MRKAd5 HIV-1 gag vaccine injected intramuscularly."},{"id":"BG001","title":"Monovalent MRKAd5 HIV-1 Gag Vaccine (1x10^9 vp/Dose)","description":"3 doses of 1.0 ml of the Monovalent MRKAd5 HIV-1 gag vaccine (1x10\\^9 vp/dose) injected intramuscularly."},{"id":"BG002","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^6 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^6 vp/dose) injected intramuscularly."},{"id":"BG003","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^7 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^7 vp/dose) injected intramuscularly."},{"id":"BG004","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^8 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^8 vp/dose) injected intramuscularly."},{"id":"BG005","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^9 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^9 vp/dose) injected intramuscularly."},{"id":"BG006","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^10 vp/Dose)","description":"2 or 3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^10 vp/dose) injected intramuscularly."},{"id":"BG007","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (1x10^11 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10\\^11 vp/dose) injected intramuscularly."},{"id":"BG008","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"42"},{"groupId":"BG003","value":"42"},{"groupId":"BG004","value":"42"},{"groupId":"BG005","value":"42"},{"groupId":"BG006","value":"78"},{"groupId":"BG007","value":"31"},{"groupId":"BG008","value":"317"}]}],"measures":[{"title":"Age, Customized","paramType":"MEAN","dispersionType":"FULL_RANGE","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"32.4","lowerLimit":"19","upperLimit":"50"},{"groupId":"BG001","value":"34.3","lowerLimit":"18","upperLimit":"46"},{"groupId":"BG002","value":"33.2","lowerLimit":"19","upperLimit":"50"},{"groupId":"BG003","value":"32.6","lowerLimit":"19","upperLimit":"50"},{"groupId":"BG004","value":"33.3","lowerLimit":"18","upperLimit":"50"},{"groupId":"BG005","value":"34.0","lowerLimit":"18","upperLimit":"50"},{"groupId":"BG006","value":"35.7","lowerLimit":"19","upperLimit":"50"},{"groupId":"BG007","value":"34.8","lowerLimit":"19","upperLimit":"50"},{"groupId":"BG008","value":"34.0","lowerLimit":"18","upperLimit":"50"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"21"},{"groupId":"BG003","value":"14"},{"groupId":"BG004","value":"17"},{"groupId":"BG005","value":"21"},{"groupId":"BG006","value":"31"},{"groupId":"BG007","value":"14"},{"groupId":"BG008","value":"149"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"21"},{"groupId":"BG003","value":"28"},{"groupId":"BG004","value":"25"},{"groupId":"BG005","value":"21"},{"groupId":"BG006","value":"47"},{"groupId":"BG007","value":"17"},{"groupId":"BG008","value":"168"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"United States","categories":[{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"42"},{"groupId":"BG003","value":"42"},{"groupId":"BG004","value":"42"},{"groupId":"BG005","value":"42"},{"groupId":"BG006","value":"78"},{"groupId":"BG007","value":"31"},{"groupId":"BG008","value":"317"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Adverse Experiences","description":"Adverse experiences (AE) collected include serious and non serious systemic AEs, and injection-site AEs.\n\nSystemic and Laboratory AEs include any unfavorable \\& unintended change in the structure, function, or chemistry of the body.\n\nInjection-site AEs include any swelling, redness, pain or tenderness at the injection site. All injection site AEs were collected up to 5 days after any vaccine dose.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"up to 260 weeks after first vaccination","groups":[{"id":"OG000","title":"Placebo","description":"2 or 3 doses of 1.0 mg of placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine or 3 doses of placebo to the MRKAd5 HIV-1 gag vaccine injected intramuscularly."},{"id":"OG001","title":"Monovalent MRKAd5 HIV-1 Gag Vaccine (1x10^9 vp/Dose)","description":"3 doses of 1.0 ml of the Monovalent MRKAd5 HIV-1 gag vaccine (1x10\\^9 vp/dose) injected intramuscularly."},{"id":"OG002","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^6 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^6 vp/dose) injected intramuscularly."},{"id":"OG003","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^7 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^7 vp/dose) injected intramuscularly."},{"id":"OG004","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^8 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^8 vp/dose) injected intramuscularly."},{"id":"OG005","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^9 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^9 vp/dose) injected intramuscularly."},{"id":"OG006","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^10 vp/Dose)","description":"2 or 3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^10 vp/dose) injected intramuscularly."},{"id":"OG007","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (1x10^11 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10\\^11 vp/dose) injected intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"41"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"42"},{"groupId":"OG005","value":"41"},{"groupId":"OG006","value":"78"},{"groupId":"OG007","value":"31"}]}],"classes":[{"title":"With non-serious systemic AEs (NSAE)","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"36"},{"groupId":"OG003","value":"33"},{"groupId":"OG004","value":"35"},{"groupId":"OG005","value":"37"},{"groupId":"OG006","value":"68"},{"groupId":"OG007","value":"28"}]}]},{"title":"With Injection site AEs","categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"17"},{"groupId":"OG003","value":"18"},{"groupId":"OG004","value":"22"},{"groupId":"OG005","value":"23"},{"groupId":"OG006","value":"57"},{"groupId":"OG007","value":"29"}]}]},{"title":"With serious systemic AEs","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"7"},{"groupId":"OG007","value":"1"}]}]},{"title":"With serious injection site AEs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Laboratory Adverse Experiences","description":"Laboratory AEs were based on a grading system considering the severity of abnormal laboratory values in participants and reflect any unfavorable and unintentional change in function, or chemistry of the body.\n\nAll laboratory AEs were collected up to 29 days after any vaccine dose.","populationDescription":"Participants administered at least one dose of study vaccine. One participant who was lost to follow-up, and another one participant who discontinued as he comply with the protocol are not included.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"up to 260 weeks after first vaccination","groups":[{"id":"OG000","title":"Placebo","description":"2 or 3 doses of 1.0 mg of placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine or 3 doses of placebo to the MRKAd5 HIV-1 gag vaccine injected intramuscularly."},{"id":"OG001","title":"Monovalent MRKAd5 HIV-1 Gag Vaccine (1x10^9 vp/Dose)","description":"3 doses of 1.0 ml of the Monovalent MRKAd5 HIV-1 gag vaccine (1x10\\^9 vp/dose) injected intramuscularly."},{"id":"OG002","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^6 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^6 vp/dose) injected intramuscularly."},{"id":"OG003","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^7 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^7 vp/dose) injected intramuscularly."},{"id":"OG004","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^8 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^8 vp/dose) injected intramuscularly."},{"id":"OG005","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^9 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^9 vp/dose) injected intramuscularly."},{"id":"OG006","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^10 vp/Dose)","description":"2 or 3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^10 vp/dose) injected intramuscularly."},{"id":"OG007","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (1x10^11 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10\\^11 vp/dose) injected intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"41"},{"groupId":"OG003","value":"42"},{"groupId":"OG004","value":"42"},{"groupId":"OG005","value":"41"},{"groupId":"OG006","value":"78"},{"groupId":"OG007","value":"31"}]}],"classes":[{"title":"With non-serious laboratory AEs","categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"12"},{"groupId":"OG005","value":"17"},{"groupId":"OG006","value":"29"},{"groupId":"OG007","value":"11"}]}]},{"title":"With serious laboratory AEs","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},{"type":"PRIMARY","title":"Immune Response by Levels of Unfractionated Gag, Pol, and Nef-specific IFN-gamma Following a 3-dose Vaccine Regimen","description":"Participants expressing HIV antigens (gag, pol and nef) secrete antigen specific interferon-gamma (IFN-gamma). Levels of unfractionated gag, pol, and nef-specific IFN-gamma were to be measured using an Enzyme Linked Immunospot Assay (ELISPOT), which measures spot forming cells per 10\\^6 peripheral blood mononuclear cells (SFC per million PBMCs).","populationDescription":"No immunogenicity analyses were performed because the results from a previous study, V520-023 (NCT00095576), which used the same vaccine as the one used in this study (NCT00849680) proved it was not efficacious.","reportingStatus":"POSTED","timeFrame":"4 weeks after booster injection","groups":[{"id":"OG000","title":"Placebo","description":"2 or 3 doses of 1.0 mg of placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine or 3 doses of placebo to the MRKAd5 HIV-1 gag vaccine injected intramuscularly."},{"id":"OG001","title":"Monovalent MRKAd5 HIV-1 Gag Vaccine (1x10^9 vp/Dose)","description":"3 doses of 1.0 ml of the Monovalent MRKAd5 HIV-1 gag vaccine (1x10\\^9 vp/dose) injected intramuscularly."},{"id":"OG002","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^6 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^6 vp/dose) injected intramuscularly."},{"id":"OG003","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^7 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^7 vp/dose) injected intramuscularly."},{"id":"OG004","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^8 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^8 vp/dose) injected intramuscularly."},{"id":"OG005","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^9 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^9 vp/dose) injected intramuscularly."},{"id":"OG006","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^10 vp/Dose)","description":"2 or 3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^10 vp/dose) injected intramuscularly."},{"id":"OG007","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (1x10^11 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10\\^11 vp/dose) injected intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"type":"PRIMARY","title":"Immune Response by Levels of Unfractionated Gag, Pol, and Nef-specific IFN-gamma Following a 2-dose Vaccine Regimen","description":"Participants expressing HIV antigens (gag, pol and nef) secrete antigen specific interferon-gamma (IFN-gamma). Levels of unfractionated gag, pol, and nef-specific IFN-gamma were to be measured using an Enzyme Linked Immunospot Assay (ELISPOT), which measures spot forming cells per 10\\^6 peripheral blood mononuclear cells (SFC per million PBMCs).\n\nNo immunogenicity analyses were performed because the results from a previous study, V520-023 (NCT00095576), which used the same vaccine as the one used in this study (NCT00849680) proved it was not efficacious.","populationDescription":"No immunogenicity analyses were performed because the results from a previous study, V520-023 (NCT00095576), which used the same vaccine as the one used in this study (NCT00849680) proved it was not efficacious.","reportingStatus":"POSTED","timeFrame":"4 weeks after booster injection","groups":[{"id":"OG000","title":"Placebo","description":"2 or 3 doses of 1.0 mg of placebo to the MRKAd5 HIV-1 gag/pol/nef vaccine or 3 doses of placebo to the MRKAd5 HIV-1 gag vaccine injected intramuscularly."},{"id":"OG001","title":"Monovalent MRKAd5 HIV-1 Gag Vaccine (1x10^9 vp/Dose)","description":"3 doses of 1.0 ml of the Monovalent MRKAd5 HIV-1 gag vaccine (1x10\\^9 vp/dose) injected intramuscularly."},{"id":"OG002","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^6 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^6 vp/dose) injected intramuscularly."},{"id":"OG003","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^7 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^7 vp/dose) injected intramuscularly."},{"id":"OG004","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^8 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^8 vp/dose) injected intramuscularly."},{"id":"OG005","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^9 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^9 vp/dose) injected intramuscularly."},{"id":"OG006","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10^10 vp/Dose)","description":"2 or 3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (3x10\\^10 vp/dose) injected intramuscularly."},{"id":"OG007","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (1x10^11 vp/Dose)","description":"3 doses of 1.0 ml of Trivalent MRKAd5 HIV-1 gag/pol/nef vaccine (1x10\\^11 vp/dose) injected intramuscularly."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","eventGroups":[{"id":"EG000","title":"Placebo","seriousNumAffected":1,"seriousNumAtRisk":26,"otherNumAffected":24,"otherNumAtRisk":26},{"id":"EG001","title":"Monovalent MRKAd5 HIV-1 Gag Vaccine (1x10[9] vp/Dose)","seriousNumAffected":2,"seriousNumAtRisk":13,"otherNumAffected":13,"otherNumAtRisk":13},{"id":"EG002","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10[6] vp/Dose)","seriousNumAffected":2,"seriousNumAtRisk":41,"otherNumAffected":35,"otherNumAtRisk":41},{"id":"EG003","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10[7] vp/Dose)","seriousNumAffected":3,"seriousNumAtRisk":42,"otherNumAffected":38,"otherNumAtRisk":42},{"id":"EG004","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10[8] vp/Dose)","seriousNumAffected":4,"seriousNumAtRisk":42,"otherNumAffected":35,"otherNumAtRisk":42},{"id":"EG005","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10[9] vp/Dose)","seriousNumAffected":3,"seriousNumAtRisk":42,"otherNumAffected":39,"otherNumAtRisk":42},{"id":"EG006","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (3x10[10] vp/Dose)","seriousNumAffected":7,"seriousNumAtRisk":78,"otherNumAffected":74,"otherNumAtRisk":78},{"id":"EG007","title":"Trivalent MRKAd5 HIV-1 Gag/Pol/Nef Vaccine (1x10[11] vp/Dose)","seriousNumAffected":1,"seriousNumAtRisk":31,"otherNumAffected":31,"otherNumAtRisk":31}],"seriousEvents":[{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Myocarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Prinzmetal angina","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Colonic polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Cholecystitis chronic","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Kidney infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Staphylococcal infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Foot fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Head injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Skull fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Electrocardiogram change","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Obesity","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Squamous cell carcinoma of skin","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Uterine leiomyoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Cerebral haemorrhage","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Suicidal ideation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]}],"otherEvents":[{"term":"Lymph node pain","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":2,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":10,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":4,"numAffected":2,"numAtRisk":31}]},{"term":"Ear discomfort","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Ear pain","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":3,"numAtRisk":26},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG002","numEvents":7,"numAffected":7,"numAtRisk":41},{"groupId":"EG003","numEvents":8,"numAffected":7,"numAtRisk":42},{"groupId":"EG004","numEvents":6,"numAffected":5,"numAtRisk":42},{"groupId":"EG005","numEvents":17,"numAffected":10,"numAtRisk":42},{"groupId":"EG006","numEvents":12,"numAffected":11,"numAtRisk":78},{"groupId":"EG007","numEvents":11,"numAffected":7,"numAtRisk":31}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":41},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":17,"numAffected":14,"numAtRisk":78},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":31}]},{"term":"Stomatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Chills","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":21,"numAffected":18,"numAtRisk":78},{"groupId":"EG007","numEvents":12,"numAffected":9,"numAtRisk":31}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG001","numEvents":6,"numAffected":4,"numAtRisk":13},{"groupId":"EG002","numEvents":8,"numAffected":5,"numAtRisk":41},{"groupId":"EG003","numEvents":10,"numAffected":7,"numAtRisk":42},{"groupId":"EG004","numEvents":8,"numAffected":6,"numAtRisk":42},{"groupId":"EG005","numEvents":14,"numAffected":12,"numAtRisk":42},{"groupId":"EG006","numEvents":23,"numAffected":20,"numAtRisk":78},{"groupId":"EG007","numEvents":18,"numAffected":12,"numAtRisk":31}]},{"term":"Feeling of body temperature change","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Injection site erythema","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":4,"numAtRisk":26},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":13},{"groupId":"EG002","numEvents":6,"numAffected":6,"numAtRisk":41},{"groupId":"EG003","numEvents":6,"numAffected":6,"numAtRisk":42},{"groupId":"EG004","numEvents":9,"numAffected":7,"numAtRisk":42},{"groupId":"EG005","numEvents":10,"numAffected":8,"numAtRisk":42},{"groupId":"EG006","numEvents":19,"numAffected":15,"numAtRisk":78},{"groupId":"EG007","numEvents":14,"numAffected":11,"numAtRisk":31}]},{"term":"Injection site haematoma","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Injection site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":5,"numAtRisk":26},{"groupId":"EG001","numEvents":19,"numAffected":8,"numAtRisk":13},{"groupId":"EG002","numEvents":18,"numAffected":13,"numAtRisk":41},{"groupId":"EG003","numEvents":20,"numAffected":13,"numAtRisk":42},{"groupId":"EG004","numEvents":40,"numAffected":21,"numAtRisk":42},{"groupId":"EG005","numEvents":42,"numAffected":22,"numAtRisk":42},{"groupId":"EG006","numEvents":114,"numAffected":56,"numAtRisk":78},{"groupId":"EG007","numEvents":68,"numAffected":29,"numAtRisk":31}]},{"term":"Injection site pruritus","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"Injection site swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":4,"numAffected":4,"numAtRisk":42},{"groupId":"EG004","numEvents":6,"numAffected":5,"numAtRisk":42},{"groupId":"EG005","numEvents":9,"numAffected":8,"numAtRisk":42},{"groupId":"EG006","numEvents":22,"numAffected":17,"numAtRisk":78},{"groupId":"EG007","numEvents":14,"numAffected":10,"numAtRisk":31}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":6,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":4,"numAffected":2,"numAtRisk":31}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":41},{"groupId":"EG003","numEvents":4,"numAffected":3,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":5,"numAffected":4,"numAtRisk":42},{"groupId":"EG006","numEvents":13,"numAffected":10,"numAtRisk":78},{"groupId":"EG007","numEvents":5,"numAffected":4,"numAtRisk":31}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":3,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":7,"numAffected":6,"numAtRisk":42},{"groupId":"EG005","numEvents":7,"numAffected":5,"numAtRisk":42},{"groupId":"EG006","numEvents":30,"numAffected":21,"numAtRisk":78},{"groupId":"EG007","numEvents":19,"numAffected":11,"numAtRisk":31}]},{"term":"Abscess limb","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Furuncle","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Localised infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":4,"numAffected":4,"numAtRisk":42},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":3,"numAffected":2,"numAtRisk":31}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":4,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG006","numEvents":5,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Pharyngitis streptococcal","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Rash pustular","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":1,"numAtRisk":31}]},{"term":"Rhinitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":26},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":13},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":41},{"groupId":"EG003","numEvents":7,"numAffected":6,"numAtRisk":42},{"groupId":"EG004","numEvents":5,"numAffected":5,"numAtRisk":42},{"groupId":"EG005","numEvents":5,"numAffected":4,"numAtRisk":42},{"groupId":"EG006","numEvents":16,"numAffected":13,"numAtRisk":78},{"groupId":"EG007","numEvents":3,"numAffected":2,"numAtRisk":31}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":3,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Excoriation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Procedural pain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Stress fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Activated partial thromboplastin time prolonged","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":10,"numAffected":8,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":5,"numAffected":3,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":5,"numAffected":3,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Bacteria urine identified","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":3,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Blood amylase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":4,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":4,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":5,"numAffected":1,"numAtRisk":31}]},{"term":"Blood bilirubin increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":4,"numAffected":4,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Blood creatine phosphokinase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG005","numEvents":8,"numAffected":4,"numAtRisk":42},{"groupId":"EG006","numEvents":8,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Blood creatinine increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Blood urine present","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":3,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":4,"numAffected":2,"numAtRisk":42},{"groupId":"EG006","numEvents":7,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Body temperature increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"C-reactive protein increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":1,"numAtRisk":31}]},{"term":"Eosinophil count increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Haematocrit decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":3,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"Haemoglobin decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":3,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":3,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"Lymphocyte count increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Neutrophil count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":6,"numAffected":5,"numAtRisk":78},{"groupId":"EG007","numEvents":4,"numAffected":3,"numAtRisk":31}]},{"term":"Neutrophil count increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Protein urine present","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":3,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":4,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Red blood cells urine positive","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":4,"numAffected":4,"numAtRisk":42},{"groupId":"EG006","numEvents":16,"numAffected":8,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Urinary sediment present","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":4,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"White blood cell count decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":3,"numAffected":2,"numAtRisk":31}]},{"term":"White blood cell count increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"White blood cells urine positive","organSystem":"Investigations","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":4,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":3,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":6,"numAffected":4,"numAtRisk":42},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":78},{"groupId":"EG007","numEvents":5,"numAffected":3,"numAtRisk":31}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":41},{"groupId":"EG003","numEvents":5,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":78},{"groupId":"EG007","numEvents":4,"numAffected":3,"numAtRisk":31}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":41},{"groupId":"EG003","numEvents":5,"numAffected":4,"numAtRisk":42},{"groupId":"EG004","numEvents":18,"numAffected":6,"numAtRisk":42},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":19,"numAffected":14,"numAtRisk":78},{"groupId":"EG007","numEvents":12,"numAffected":8,"numAtRisk":31}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":4,"numAffected":4,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":24,"numAffected":12,"numAtRisk":26},{"groupId":"EG001","numEvents":12,"numAffected":6,"numAtRisk":13},{"groupId":"EG002","numEvents":25,"numAffected":10,"numAtRisk":41},{"groupId":"EG003","numEvents":17,"numAffected":13,"numAtRisk":42},{"groupId":"EG004","numEvents":26,"numAffected":13,"numAtRisk":42},{"groupId":"EG005","numEvents":19,"numAffected":12,"numAtRisk":42},{"groupId":"EG006","numEvents":69,"numAffected":35,"numAtRisk":78},{"groupId":"EG007","numEvents":23,"numAffected":14,"numAtRisk":31}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Agitation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":5,"numAffected":3,"numAtRisk":41},{"groupId":"EG003","numEvents":4,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":7,"numAffected":4,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":6,"numAffected":6,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Dysuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":5,"numAffected":5,"numAtRisk":41},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":9,"numAffected":8,"numAtRisk":42},{"groupId":"EG005","numEvents":6,"numAffected":6,"numAtRisk":42},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Nasal congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":7,"numAffected":6,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":12,"numAffected":10,"numAtRisk":78},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":31}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":6,"numAtRisk":26},{"groupId":"EG001","numEvents":6,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":11,"numAffected":8,"numAtRisk":41},{"groupId":"EG003","numEvents":5,"numAffected":5,"numAtRisk":42},{"groupId":"EG004","numEvents":18,"numAffected":12,"numAtRisk":42},{"groupId":"EG005","numEvents":16,"numAffected":10,"numAtRisk":42},{"groupId":"EG006","numEvents":16,"numAffected":13,"numAtRisk":78},{"groupId":"EG007","numEvents":3,"numAffected":3,"numAtRisk":31}]},{"term":"Rhinorrhoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Sinus congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG005","numEvents":4,"numAffected":4,"numAtRisk":42},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Dermatitis contact","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":4,"numAffected":3,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":26},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":13},{"groupId":"EG002","numEvents":3,"numAffected":2,"numAtRisk":41},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":42},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":42},{"groupId":"EG005","numEvents":3,"numAffected":3,"numAtRisk":42},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":78},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":31}]},{"term":"Flushing","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 12.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":26},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":13},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":41},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":42},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":78},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":31}]}]},"moreInfoModule":{"limitationsAndCaveats":{"description":"An interim analysis of a related study, V520 Protocol 023 (NCT00095576), showed that the MRKAd5 vaccine used in Protocol 016 (NCT00849680) was not efficacious; therefore, only a high level summary of the safety data was performed."},"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"As this study is part of a multicenter trial, publications derived from this study should include input from the principal investigator, his/her colleagues, the other investigators in this trial, and SPONSOR personnel.\n\nThe SPONSOR must have the opportunity to review all proposed abstracts, manuscripts, or presentations regarding this study 60 days prior to submission for publication/presentation. SPONSOR review can be expedited to meet publication guidelines."},"pointOfContact":{"title":"Senior Vice President, Global Clinical Development","organization":"Merck Sharp & Dohme Corp.","email":"clinicaltrialsdisclosure@merck.com"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D015658","term":"HIV Infections"}],"ancestors":[{"id":"D000086982","term":"Blood-Borne Infections"},{"id":"D003141","term":"Communicable Diseases"},{"id":"D007239","term":"Infections"},{"id":"D015229","term":"Sexually Transmitted Diseases, Viral"},{"id":"D012749","term":"Sexually Transmitted Diseases"},{"id":"D016180","term":"Lentivirus Infections"},{"id":"D012192","term":"Retroviridae Infections"},{"id":"D012327","term":"RNA Virus Infections"},{"id":"D014777","term":"Virus Diseases"},{"id":"D000091662","term":"Genital Diseases"},{"id":"D000091642","term":"Urogenital Diseases"},{"id":"D007153","term":"Immunologic Deficiency Syndromes"},{"id":"D007154","term":"Immune System Diseases"}]}},"hasResults":true}